Back to Search
Start Over
InnoCare Pharma begins patient dosing in clinical trial of TYK2 JH2 allosteric inhibitor ICP-488 in China
- Source :
- PharmaBiz. July 6, 2023
- Publication Year :
- 2023
-
Abstract
- InnoCare Pharma, a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced the first psoriasis patient has been dosed in clinical trial of the company's TYK2 [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PharmaBiz
- Publication Type :
- Periodical
- Accession number :
- edsgcl.756046131